BackEnanta Pharmaceuticals Overview

Enanta Pharmaceuticals Other Current Assets

Latest other current assets for ENTA: $6.8M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$6.81M
84.05% YoYΔ $-35.88M vs prior year quarter

Peer average

Loading

Enanta Pharmaceuticals Other Current Assets History

Loading

Enanta Pharmaceuticals vs. peers: Other Current Assets Comparison

Loading

Enanta Pharmaceuticals Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Enanta Pharmaceuticals (ENTA) FAQ

As of the most recent data (March 2026), ENTA shows a other current assets of $6.8M. That compares with $43M in the prior-year period — down 84.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ENTA's other current assets is now $6.8M (was $43M) — a 84.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Enanta Pharmaceuticals is outperforming or lagging.

Tracking ENTA's other current assets over time shows whether Enanta Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $6.8M That compares with $43M in the prior-year period — down 84.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Enanta Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $6.8M) with ownership activity and broader fundamentals.

Enanta Pharmaceuticals's other current assets is $6.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.